Endometrial receptivity analysis, endometrial microbiome testing, screening for chronic endometritis, and referral to a facility offering platelet-rich plasma (PRP) therapy or granulocyte colony-stimulating factor (G-CSF) therapy were suggested. The gene discussed is CSF3; the disease is chronic endometritis.